Kevin P Moore

Kevin  P Moore

University College London

H-index: 65

Europe-United Kingdom

About Kevin P Moore

Kevin P Moore, With an exceptional h-index of 65 and a recent h-index of 31 (since 2020), a distinguished researcher at University College London, specializes in the field of liver.

His recent articles reflect a diverse array of research interests and contributions to the field:

AlcoChange: A digital therapeutic for patients with alcohol-related liver disease

Application of physiological network mapping in the prediction of survival in critically ill patients with acute liver failure

Development and Clinical Evaluation of AlcoChange: a Digital Therapeutic for Patients with Alcohol-Related Liver Disease

Dr. L. Jackson Roberts II

The effect of precipitating factors for hepatorenal syndrome on response to terlipressin treatment: A subgroup analysis of a pooled North American database

Parenclitic network mapping identifies response to targeted albumin therapy in patients hospitalized with decompensated cirrhosis

Diagnostic accuracy of the Abbott ID NOW SARS-CoV-2 rapid test for the triage of acute medical admissions

Prognosis and survival modelling in cirrhosis using parenclitic networks

Kevin P Moore Information

University

Position

Professor of Hepatology Royal Free Campus

Citations(all)

20937

Citations(since 2020)

6030

Cited By

15028

hIndex(all)

65

hIndex(since 2020)

31

i10Index(all)

122

i10Index(since 2020)

66

Email

University Profile Page

University College London

Google Scholar

View Google Scholar Profile

Kevin P Moore Skills & Research Interests

liver

Top articles of Kevin P Moore

Title

Journal

Author(s)

Publication Date

AlcoChange: A digital therapeutic for patients with alcohol-related liver disease

JHEP Reports

Gautam Mehta

Su Lin

Aida Nadar

PV Bharadwaj

Ravi Kumar

...

2024/4/1

Application of physiological network mapping in the prediction of survival in critically ill patients with acute liver failure

medRxiv

Tope Oyelade

Kevin P Moore

Ali R Mani

2024

Development and Clinical Evaluation of AlcoChange: a Digital Therapeutic for Patients with Alcohol-Related Liver Disease

medRxiv

Gautam Mehta

Su Lin

Bharadwaj PV

Ravi Kumar

Anu Balaji

...

2023

Dr. L. Jackson Roberts II

Sean S Davies

Joshua P Fessel

Ginger L Milne

Kevin Moore

Huiyong Yin

2023/10

The effect of precipitating factors for hepatorenal syndrome on response to terlipressin treatment: A subgroup analysis of a pooled North American database

Abstract to be presented at the European Association for the Study of the Liver (EASL) 2023 Liver Congress

Kevin Moore

Zunaira Zafar

Nikolaos T Pyrsopoulos

Khurram Jamil

2023/6/1

Parenclitic network mapping identifies response to targeted albumin therapy in patients hospitalized with decompensated cirrhosis

Clinical and Translational Gastroenterology

Tope Oyelade

Ewan Forrest

Kevin P Moore

Alastair O'Brien

Ali R Mani

2023/6/1

Diagnostic accuracy of the Abbott ID NOW SARS-CoV-2 rapid test for the triage of acute medical admissions

Journal of Hospital Infection

JR Barnacle

H Houston

I Baltas

J Takata

K Kavallieros

...

2022/5/1

Prognosis and survival modelling in cirrhosis using parenclitic networks

Frontiers in Network Physiology

Han Zhang

Tope Oyelade

Kevin P Moore

Sara Montagnese

Alireza Mani

2022/2/21

real‐world use of terlipressin in patients with the hepatorenal syndrome—authors' reply.

Alimentary Pharmacology & Therapeutics

Andrew S Allegretti

Khurram Jamil

Kevin Moore

2021/8/1

Heart rate variability in patients with cirrhosis: a systematic review and meta-analysis

Tope Oyelade

Gabriele Canciani

Gabriele Carbone

Jaber S Alqahtani

Kevin Moore

...

2021/6/17

Directrices sobre el tratamiento de la ascitis en la cirrosis

Gut

Guruprasad P Aithal

Naaventhan Palaniyappan

Louise China

Suvi Härmälä

Lucia Macken

...

2021/1

Guidelines on the management of ascites in cirrhosis

Gut

Guruprasad P Aithal

Naaventhan Palaniyappan

Louise China

Suvi Härmälä

Lucia Macken

...

2021/1/1

S375 Real World Treatment Patterns and Outcomes in Patients With Esophageal Variceal Bleeding and Liver Cirrhosis in United Kingdom

Official journal of the American College of Gastroenterology| ACG

Kevin Moore

Xingyue Huang

Sneha S Kelkar

Rutika Raina

Shelby L Corman

...

2021/10/1

S1166 Serum Creatinine≥ 5 mg/dL Is Associated With Decreased Safety and Efficacy in Patients Treated With Terlipressin for Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI …

Official journal of the American College of Gastroenterology| ACG

Andrew S Allegretti

Khurram Jamil

Katharina Verleger

Shelby L Corman

Nehemiah Kebede

...

2021/10/1

HRS‐AKI—a frequent misdiagnosis in the real world setting? Authors' reply.

Alimentary Pharmacology & Therapeutics

Kevin Moore

Khurram Jamil

Andrew S Allegretti

2020/9/15

treating hepatorenal syndrome—a window and the views. Authors' reply.

Alimentary Pharmacology & Therapeutics

Andrew S Allegretti

Khurram Jamil

Kevin Moore

2020/9/1

Real‐world treatment patterns and outcomes using terlipressin in 203 patients with the hepatorenal syndrome

Alimentary Pharmacology & Therapeutics

Kevin Moore

Khurram Jamil

Katharina Verleger

Linlin Luo

Nehemiah Kebede

...

2020/7

Heart rate turbulence predicts survival independently from severity of liver dysfunction in patients with cirrhosis

Frontiers in physiology

Tope Oyelade

Gabriele Canciani

Matteo Bottaro

Marta Zaccaria

Chiara Formentin

...

2020/12/9

Role of terlipressin and albumin for hepatorenal syndrome in liver transplantation

Pratima Sharma

Kevin Moore

Daniel Ganger

Priya Grewal

Robert S Brown Jr

2020/10

See List of Professors in Kevin P Moore University(University College London)